» Articles » PMID: 27722156

Evaluation of Expression in Esophageal Cancer Patients

Overview
Date 2016 Oct 11
PMID 27722156
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Esophageal cancer is a public health concern around the world; this cancer is the sixth leading cause of death of cancer in the world with about 386,000 deaths per year. Its risk factors include environmental factors such as tobacco smoke, gastroesophageal reflux and genetic changes. is stated by the effect of various inflammatory factors and is thus called inducible NOS. Investigating expression is a powerful tool for understanding effective molecular parameters at tissue and cellular responses to external factors. In this research work, expression in patients with esophageal cancer was studied in Iran.

Materials And Methods: 15 formalin-fixed and paraffin-embedded (FFPE) esophageal cancer tissue samples and 15 normal FFPE samples were collected from various medical centers (Zabol, Zahedan, Kashan) to measure expression by real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR). All PCR reactions were conducted by three replicates for and internal control (β-actin) by 2 (Livak) method. Differences were measured in target gene expression in patients and control group using the t test. All statistical analyses were done using the SPSS software.

Results: The results showed that there was no significant difference between expression in the case and control groups (p > 0.05); however, there was an increase in expression in the case group. On the other hand, there was a significant difference between expression in males and females in the two groups of healthy subjects and patients, and it was higher in women than in men.

Conclusion: Further studies need to be conducted with larger sample sizes and in other populations to validate these findings.

Citing Articles

NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.

Coutinho L, Femino E, Gonzalez A, Moffat R, Heinz W, Cheng R Int J Mol Sci. 2024; 25(11).

PMID: 38892290 PMC: 11173351. DOI: 10.3390/ijms25116103.


Inflammation-Associated Cytotoxic Agents in Tumorigenesis.

Arnhold J Cancers (Basel). 2024; 16(1).

PMID: 38201509 PMC: 10778456. DOI: 10.3390/cancers16010081.


Chemopreventive Properties of Black Raspberries and Strawberries in Esophageal Cancer Review.

Shi N, Chen T Antioxidants (Basel). 2022; 11(9).

PMID: 36139889 PMC: 9495642. DOI: 10.3390/antiox11091815.


Immunosuppressive Phenotype of Esophagus Tumors Stroma.

Kovaleva O, Rashidova M, Samoilova D, Podlesnaya P, Mochalnikova V, Gratchev A Anal Cell Pathol (Amst). 2020; 2020:5424780.

PMID: 32884895 PMC: 7455837. DOI: 10.1155/2020/5424780.

References
1.
Motalleb G, Gholipour N, Mansour Samaei N . Association of the human astrocyte elevated gene-1 promoter variants with susceptibility to hepatocellular carcinoma. Med Oncol. 2014; 31(4):916. DOI: 10.1007/s12032-014-0916-5. View

2.
Kroncke K, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H . Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun. 1991; 175(3):752-8. DOI: 10.1016/0006-291x(91)91630-u. View

3.
Musial A, Eissa N . Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J Biol Chem. 2001; 276(26):24268-73. DOI: 10.1074/jbc.M100725200. View

4.
Ribeiro Jr U, Posner M, Safatle-Ribeiro A, Reynolds J . Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996; 83(9):1174-85. View

5.
Chong M, Thomas H, Kay T . Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor. J Biol Chem. 2002; 277(31):27945-52. DOI: 10.1074/jbc.M110214200. View